Growth Strategies in Pharma

Strategies for Growth in Pharma Environment track mainly focused in Strategic development towards FDA approval and Post market product surveillances.

The updates and advances in Pharmacovigilance regulation system are discussed in Advances in changing Pharmacovigilance regulation system track. The Pharma industry is looking to fast-growth emerging markets to fuel their growth, especially for the generics business. The global market for marine-derived drugs by type was around $4.8 billion in 2011, which is expected to be around $5.3 billion in 2012. This global market is forecasted to reach $8.6 billion by 2016 at a compound annual growth rate (CAGR) of 12.5% for the five year period of 2011 to 2016.

  • Strategic Development towards FDA Approval
  • Post Market Product Surveillances
  • Advances in Changing Pharmacovigilance Regulation System

Related Conference of Growth Strategies in Pharma

June 06-07, 2018

International Conference & B2B on Pharma Research and Development

Philadelphia, Pennsylvania, USA
June 27-28, 2018

4th International Conference on Drug Discovery, Designing and Development

Vancouver, British Columbia, Canada
August 20-21, 2018

12th Asian Biologics and Biosimilars Congress

Tokyo, Japan
October 18-20, 2018

18th World Pharma Congress

Warsaw, Poland
November 15-16, 2018

14th International Conference on Generic Drugs and Biosimilars

Frankfurt, Germany
September 18-19, 2018

6 th European Biopharma Congress

Amsterdam, Netherlands

Growth Strategies in Pharma Conference Speakers

Recommended Sessions

Related Journals

Are you interested in